Previous close | 25.07 |
Open | 25.04 |
Bid | 24.93 x 300 |
Ask | 25.04 x 200 |
Day's range | 24.66 - 25.25 |
52-week range | 13.36 - 27.50 |
Volume | |
Avg. volume | 370,932 |
Market cap | 683.238M |
Beta (5Y monthly) | -0.31 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
AnaptysBio (ANAB) delivered earnings and revenue surprises of -6.49% and 57.78%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
AnaptysBio (ANAB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AnaptysBio (ANAB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.